PND26 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS IN SPAIN
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74820-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)74820-8/fulltext
Title :
PND26 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS IN SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74820-8&doi=10.1016/S1098-3015(10)74820-8
First page :
Section Title :
Open access? :
No
Section Order :
745